Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Anthem Biosciences Limited (NSE: ANTHEM), ISIN INE0CZ201020 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ANTHEM last traded at ₹887.95 (+0.68%), with a 52-week range of ₹579.45 to ₹977.00 (as of 23 Sep 2026).
Shareholding as of Jun 2026: promoters 71.42%, FIIs 2.58%, DIIs 13.48%, mutual funds 11.15%.
EquiSense Score (ECS): 50/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.